camptothecin has been researched along with 4,5,6,7-tetrabromo-2-azabenzimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kozłowska, E; Orzechowska, E; Staroń, K; Trzcińska-Danielewicz, J | 1 |
1 other study(ies) available for camptothecin and 4,5,6,7-tetrabromo-2-azabenzimidazole
Article | Year |
---|---|
Time schedule-dependent effect of the CK2 inhibitor TBB on PC-3 human prostate cancer cell viability.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 2; Enzyme Inhibitors; Humans; Male; Prostatic Neoplasms; Protein Serine-Threonine Kinases; TNF-Related Apoptosis-Inducing Ligand; Triazoles | 2012 |